Select a Region
North America

Browsing Archive: ArticleArticle | EVERSANA - Part 5

EVERSANA
Posted on November 26, 202411/26/24

Health Economics Studies Assessment of the 2ND China Rare Disease Catalogue: A Scoping Review

EVERSANA
Posted on November 26, 202411/26/24

CAR-T Cell Therapy Accessibility: A Targeted Review of Access Challenges and Opportunities in APAC Region

EVERSANA
Posted on November 26, 202411/26/24

Model-Projected Clinical Outcomes of Exagamglogene Autotemcel (exa-cel) in Patients With Sickle Cell Disease With Recurrent Vaso-Occlusive Crises in Canada

EVERSANA
Posted on November 26, 202411/26/24

Budget Impact Analyses of Hemoglobin a1C and Lipid Panel Point-of-Care Testing With Afinion™ 2 in Italy and Canada

EVERSANA
Posted on November 26, 202411/26/24

Treatment Patterns and Economic Burden of Guillain-Barré Syndrome: A Systematic Review

EVERSANA
Posted on November 26, 202411/26/24

Evaluating the Clinical and Socioeconomic Impact of Improved CKD Diagnosis and Adherence to Guideline-Directed Medical Therapy in Australia, Brazil, and China: An Impact CKD Analysis

EVERSANA
Posted on November 26, 202411/26/24

Model-Projected Clinical Outcomes of Exagamglogene Autotemcel (exa-cel) in Patients With Transfusion-Dependent Beta-Thalassemia in Canada

EVERSANA
Posted on November 26, 202411/26/24

Systematic Literature Review of Cost-Effectiveness Evaluations of Freestyle Libre Continuous Glucose Monitoring Systems

EVERSANA
Posted on November 26, 202411/26/24

Systematic Literature Review (SLR) of Randomized Controlled Trials (RCTs) of Treatments for First-Line (1L) Gastric Cancer/Gastroesophageal Junction Adenocarcinoma (GC/GEJ) in Adult Patients

EVERSANA
Posted on November 26, 202411/26/24

Patient-Centric Approaches in Rare Disorder Research: An In-Depth Systematic Review

Article